Build status - In Progress

Patients Who Have Completed a Previous Oncology Study With Olaparib (ROSY-O)

Patients Who Have Completed a Previous Oncology Study With Olaparib (ROSY-O)
Enrolling By Invitation
18 years - 99 years
Female
Phase N/A
3 participants needed
1 Location

Brief description of study

Prior participants of ROSY-O study

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Ovarian Cancer,Breast Cancer,Cancer
  • Age: 18 years - 99 years
  • Gender: Female

Females Age 18-99 prior participation in ROSY-O study

Updated on 04 Aug 2024. Study ID: 844167
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research